ADA Scientific Sessions 2025 Abstract

Comparative Effects of Enavogliflozin vs. Dapagliflozin on Adipokines in Patients with Type 2 Diabetes Mellitus

By Young Sang Lyu, Kyung-Soo Kim, Cheol-Young Park, Sangmo Hong

Trial in peopleInterventions

The paper

Young Sang Lyu, Kyung-Soo Kim, Cheol-Young Park, Sangmo Hong

Gwang-ju

ADA Scientific Sessions 2025 Abstract, 13 Jun 2025

Presented at ADA Scientific Sessions 2025, late-breaking 2194-LB

doi.org/10.2337/db25-2194-lb

Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Clinical Journal of the American Society of Nephrology4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Frontiers in Endocrinology4 Oct 2026
Underweight is linked to higher kidney disease risk in diabetes